Enterprise Financial Services Corp Grifols Sa Transaction History

Enterprise Financial Services Corp

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 12, 2021	SELL	$16.86 - $19.67 $84 - $98	-5 Closed	0 $0
Q3 2020 Nov 13, 2020	SELL	$15.4 - $20.16 $862 - $1,128	-56 Reduced 91.8%	5 $0
Q2 2020 Aug 04, 2020	SELL	$18.24 - $21.45 $729 - $858	-40 Reduced 39.6%	61 $1,000
Q1 2020 May 15, 2020	BUY	$16.28 - $25.63 $667 - $1,050	41 Added 68.33%	101 $2,000
Q2 2019 Jul 30, 2019	BUY	$17.59 - $21.1 $967 - $1,160	55 Added 1100.0%	60 $1,000
Q1 2019 Apr 26, 2019	SELL	$18.01 - $20.11 $3,079 - $3,438	-171 Reduced 97.16%	5 $0
Q2 2018 Jul 27, 2018	SELL	$20.16 - $24.68 $7,116 - $8,712	-353 Reduced 66.73%	176 $4,000
Q1 2018 Apr 27, 2018	BUY	$20.31 - $24.95 $7,169 - $8,807	353 Added 200.57%	529 $11,000
Q3 2017 Oct 27, 2017	BUY	$20.07 - $21.89 $3,532 - $3,852	176	176 $4,000

164

140M

288K

389K

Ticker GRFS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 678,910,976
Market Cap $5.33B
Description
Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives. The company operates through Bioscience, Hospital, Diagnostic, Bio Supplies, and Others divisions. The Bioscience division researches, develops, produces, and markets plasma-derived medicines and other innovative solut...

Get notified when there are updates to the investment portfolio of Enterprise Financial Services Corp, based on Form 13F filings with the SEC.

Stay updated on Enterprise Financial Services Corp with notifications on news.